The anti-CD4 antibody did not affect tumor progression in both CL-Can and PBS-Can (Extended Data Fig. 7c, d) although the anti-CD4 antibody depleted CD4+ T cells from tumor tissue (Extended Data Fig. 7e). The gene discussed is CD4; the disease is neoplasm.